Danone's Open Innovation Model
Danone's Irini Schoeman-Giziakis discusses open innovation, nutrition in the GLP-1 era, and artificial intelligence.
The company is focused on meeting the nutritional needs of people taking GLP-1 drugs or trying to retain weight loss after coming off them.
It's early days
for Danone's engagement with the GLP-1 trend, says Schoeman-Giziakis. There are discussions on whether to position existing products as "GLP-1 friendly" or guide patients towards them via nutrition or online shopping apps.
Author's summary: Danone explores open innovation in AI and nutrition.